Parma, Italy

Anna Maria Capelli

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Rho-Kinase Inhibitors. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Maria Capelli. Retrieved from https://idiyas.com/inventor/anna-maria-capelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 50.0

 

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Dihydrofuropyridine
Tyrosine Analogues
Bicyclic Dihydropyrimidine
Pyrazole Derivatives
Chromene Derivatives
Pyridazinone
Indolizine
Isochromene
Isoxazolidine
Pyrrolidine
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Maria Capelli

Introduction

Anna Maria Capelli is a distinguished inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target Rho-kinase enzymes. With a total of 12 patents to her name, her work has the potential to impact the treatment of various pulmonary diseases.

Latest Patents

Among her latest patents are two notable inventions. The first is titled "Tyrosine analogues derivatives as Rho-kinase inhibitors." This invention relates to compounds that inhibit Rho Kinase and are particularly useful in treating disorders associated with ROCK enzyme mechanisms. These disorders include pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH). The second patent, "Tyrosine amide derivatives as Rho-Kinase inhibitors," describes bicyclic dihydropyrimidine-carboxamide compounds that also inhibit Rho Kinase and may be used for similar therapeutic applications.

Career Highlights

Anna Maria Capelli is currently employed at Chiesi Farmaceutici S.p.a., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in the field has led to advancements that could significantly improve patient outcomes in respiratory health.

Collaborations

Throughout her career, Anna has collaborated with talented individuals such as Alessandro Accetta and Matteo Biagetti. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Anna Maria Capelli's contributions to the field of pharmaceuticals, particularly in the development of Rho-kinase inhibitors, highlight her innovative spirit and dedication to improving health outcomes. Her work continues to pave the way for advancements in the treatment of pulmonary diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…